Early Detection of Cardiac Toxicity in Childhood Cancer Survivors

NCT03038997 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2018-12-04

No results posted yet for this study

Summary

To evaluate cardiac MRI and/or serum biomarkers for detecting cardiac cardiac toxicity in children who received anthracycline based chemotherapy (ABC).

Conditions

Sponsors & Collaborators

  • Niti Dham

    lead OTHER

Principal Investigators

  • Niti Dham, MD · Children's National Research Institute

Eligibility

Min Age
8 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-03-11
Completion
2018-03-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03038997 on ClinicalTrials.gov